A meta-analysis in patients receiving rhBMP-2 in spinal fusion found a slight increase in cancer rates; however, it was determined inconclusive as the finding did not reach statistical significance. 10 Our results indicate that mandibular grafting with DBX, rhBMP-2, and FDBC is a versatile and reliable reconstructive option for bony defects of the mandible with success rates that are comparable to other described allogenic grafting methods. 3 , 6 – 8 We experienced no graft failures, although 2 defect sites demonstrated an 80% graft take.
← all excerpts
Successful Grafting with Allogenic Bone Following Benign Pediatric Mandibular Tumor Removal.
1
—
—